{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:52:41Z","timestamp":1777038761163,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":72,"publisher":"Springer New York","isbn-type":[{"value":"9781493991501","type":"print"},{"value":"9781493991518","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9151-8_7","type":"book-chapter","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T17:11:58Z","timestamp":1550509918000},"page":"139-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Stereotyped B Cell Receptor Immunoglobulins in B Cell Lymphomas"],"prefix":"10.1007","author":[{"given":"Andreas","family":"Agathangelidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotis","family":"Psomopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi N, Ferrarini M (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 21:841\u2013894. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141018","journal-title":"Annu Rev Immunol"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-230X(01)83004-9","volume":"83","author":"FK Stevenson","year":"2001","unstructured":"Stevenson FK, Sahota SS, Ottensmeier CH et al (2001) The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv Cancer Res 83:81\u2013116","journal-title":"Adv Cancer Res"},{"issue":"6","key":"7_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.semcancer.2013.07.006","volume":"23","author":"LA Sutton","year":"2013","unstructured":"Sutton LA, Agathangelidis A, Belessi C et al (2013) Antigen selection in B-cell lymphomas\u2014tracing the evidence. Semin Cancer Biol 23(6):399\u2013409. https:\/\/doi.org\/10.1016\/j.semcancer.2013.07.006","journal-title":"Semin Cancer Biol"},{"issue":"1405","key":"7_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1098\/rstb.2000.0751","volume":"356","author":"D Dunn-Walters","year":"2001","unstructured":"Dunn-Walters D, Thiede C, Alpen B et al (2001) Somatic hypermutation and B-cell lymphoma. Philos Trans R Soc Lond Ser B Biol Sci 356(1405):73\u201382. https:\/\/doi.org\/10.1098\/rstb.2000.0751","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"2","key":"7_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/scbi.2001.0423","volume":"12","author":"P Ghia","year":"2002","unstructured":"Ghia P, Granziero L, Chilosi M et al (2002) Chronic B cell malignancies and bone marrow microenvironment. Semin Cancer Biol 12(2):149\u2013155. https:\/\/doi.org\/10.1006\/scbi.2001.0423","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"7_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott DW, Gascoyne RD (2014) The tumour microenvironment in B cell lymphomas. Nat Rev Cancer 14(8):517\u2013534. https:\/\/doi.org\/10.1038\/nrc3774","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"7_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","volume":"34","author":"JA Burger","year":"2013","unstructured":"Burger JA, Chiorazzi N (2013) B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol 34(12):592\u2013601. https:\/\/doi.org\/10.1016\/j.it.2013.07.002","journal-title":"Trends Immunol"},{"issue":"5","key":"7_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/joim.12600","volume":"282","author":"M Jerkeman","year":"2017","unstructured":"Jerkeman M, Hallek M, Dreyling M et al (2017) Targeting of B-cell receptor signalling in B-cell malignancies. J Intern Med 282(5):415\u2013428. https:\/\/doi.org\/10.1111\/joim.12600","journal-title":"J Intern Med"},{"issue":"8","key":"7_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S et al (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102(8):1515\u20131525. https:\/\/doi.org\/10.1172\/JCI3009","journal-title":"J Clin Invest"},{"issue":"6","key":"7_CR10","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94(6):1840\u20131847","journal-title":"Blood"},{"issue":"6","key":"7_CR11","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A et al (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94(6):1848\u20131854","journal-title":"Blood"},{"issue":"1","key":"7_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.leu.2404457","volume":"21","author":"P Ghia","year":"2007","unstructured":"Ghia P, Stamatopoulos K, Belessi C et al (2007) ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 21(1):1\u20133. https:\/\/doi.org\/10.1038\/sj.leu.2404457","journal-title":"Leukemia"},{"issue":"6","key":"7_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/leu.2011.49","volume":"25","author":"AW Langerak","year":"2011","unstructured":"Langerak AW, Davi F, Ghia P et al (2011) Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia 25(6):979\u2013984. https:\/\/doi.org\/10.1038\/leu.2011.49","journal-title":"Leukemia"},{"issue":"7","key":"7_CR14","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/leu.2017.125","volume":"31","author":"R Rosenquist","year":"2017","unstructured":"Rosenquist R, Ghia P, Hadzidimitriou A et al (2017) Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations. Leukemia 31(7):1477\u20131481. https:\/\/doi.org\/10.1038\/leu.2017.125","journal-title":"Leukemia"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D et al (2018) Guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia. Blood 131:2745\u20132760. https:\/\/doi.org\/10.1182\/blood-2017-09-806398","journal-title":"Blood"},{"issue":"9","key":"7_CR16","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood.V87.9.3869.bloodjournal8793869","volume":"87","author":"DG Efremov","year":"1996","unstructured":"Efremov DG, Ivanovski M, Siljanovski N et al (1996) Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 87(9):3869\u20133876","journal-title":"Blood"},{"issue":"1","key":"7_CR17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","volume":"158","author":"TA Johnson","year":"1997","unstructured":"Johnson TA, Rassenti LZ, Kipps TJ (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 158(1):235\u2013246","journal-title":"J Immunol"},{"issue":"1","key":"7_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4049\/jimmunol.166.1.95","volume":"166","author":"GF Widhopf 2nd","year":"2001","unstructured":"Widhopf GF 2nd, Kipps TJ (2001) Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 166(1):95\u2013102","journal-title":"J Immunol"},{"issue":"12","key":"7_CR19","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2002-11-3485","volume":"101","author":"G Tobin","year":"2003","unstructured":"Tobin G, Thunberg U, Johnson A et al (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 101(12):4952\u20134957. https:\/\/doi.org\/10.1182\/blood-2002-11-3485","journal-title":"Blood"},{"issue":"7","key":"7_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1172\/JCI19399","volume":"113","author":"F Ghiotto","year":"2004","unstructured":"Ghiotto F, Fais F, Valetto A et al (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 113(7):1008\u20131016. https:\/\/doi.org\/10.1172\/JCI19399","journal-title":"J Clin Invest"},{"issue":"4","key":"7_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.20040544","volume":"200","author":"BT Messmer","year":"2004","unstructured":"Messmer BT, Albesiano E, Efremov DG et al (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200(4):519\u2013525. https:\/\/doi.org\/10.1084\/jem.20040544","journal-title":"J Exp Med"},{"issue":"9","key":"7_CR22","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","volume":"104","author":"G Tobin","year":"2004","unstructured":"Tobin G, Thunberg U, Karlsson K et al (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104(9):2879\u20132885. https:\/\/doi.org\/10.1182\/blood-2004-01-0132","journal-title":"Blood"},{"issue":"8","key":"7_CR23","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","volume":"104","author":"GF Widhopf 2nd","year":"2004","unstructured":"Widhopf GF 2nd, Rassenti LZ, Toy TL et al (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104(8):2499\u20132504. https:\/\/doi.org\/10.1182\/blood-2004-03-0818","journal-title":"Blood"},{"issue":"10","key":"7_CR24","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","volume":"106","author":"K Stamatopoulos","year":"2005","unstructured":"Stamatopoulos K, Belessi C, Hadzidimitriou A et al (2005) Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 106(10):3575\u20133583. https:\/\/doi.org\/10.1182\/blood-2005-04-1511","journal-title":"Blood"},{"issue":"3","key":"7_CR25","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray F, Darzentas N, Hadzidimitriou A et al (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 111(3):1524\u20131533. https:\/\/doi.org\/10.1182\/blood-2007-07-099564","journal-title":"Blood"},{"issue":"4","key":"7_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","volume":"144","author":"R Bomben","year":"2009","unstructured":"Bomben R, Dal Bo M, Capello D et al (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 144(4):492\u2013506. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07469.x","journal-title":"Br J Haematol"},{"issue":"1","key":"7_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/leu.2009.186","volume":"24","author":"N Darzentas","year":"2010","unstructured":"Darzentas N, Hadzidimitriou A, Murray F et al (2010) A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 24(1):125\u2013132. https:\/\/doi.org\/10.1038\/leu.2009.186","journal-title":"Leukemia"},{"issue":"1","key":"7_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","volume":"109","author":"K Stamatopoulos","year":"2007","unstructured":"Stamatopoulos K, Belessi C, Moreno C et al (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109(1):259\u2013270. https:\/\/doi.org\/10.1182\/blood-2006-03-012948","journal-title":"Blood"},{"issue":"19","key":"7_CR29","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","volume":"119","author":"A Agathangelidis","year":"2012","unstructured":"Agathangelidis A, Darzentas N, Hadzidimitriou A et al (2012) Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 119(19):4467\u20134475. https:\/\/doi.org\/10.1182\/blood-2011-11-393694","journal-title":"Blood"},{"issue":"4","key":"7_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/bjh.12893","volume":"166","author":"J Malcikova","year":"2014","unstructured":"Malcikova J, Stalika E, Davis Z et al (2014) The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors. Br J Haematol 166(4):621\u2013625. https:\/\/doi.org\/10.1111\/bjh.12893","journal-title":"Br J Haematol"},{"issue":"9","key":"7_CR31","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.3324\/haematol.2016.142968","volume":"101","author":"V Navrkalova","year":"2016","unstructured":"Navrkalova V, Young E, Baliakas P et al (2016) ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres. Haematologica 101(9):e369\u2013e373. https:\/\/doi.org\/10.3324\/haematol.2016.142968","journal-title":"Haematologica"},{"issue":"11","key":"7_CR32","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1038\/leu.2013.98","volume":"27","author":"JC Strefford","year":"2013","unstructured":"Strefford JC, Sutton LA, Baliakas P et al (2013) Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia 27(11):2196\u20132199. https:\/\/doi.org\/10.1038\/leu.2013.98","journal-title":"Leukemia"},{"issue":"8","key":"7_CR33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3324\/haematol.2016.141812","volume":"101","author":"LA Sutton","year":"2016","unstructured":"Sutton LA, Young E, Baliakas P et al (2016) Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica 101(8):959\u2013967. https:\/\/doi.org\/10.3324\/haematol.2016.141812","journal-title":"Haematologica"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2119\/molmed.2013.00005","volume":"19","author":"N Papakonstantinou","year":"2013","unstructured":"Papakonstantinou N, Ntoufa S, Chartomatsidou E et al (2013) Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia. Mol Med 19:115\u2013123. https:\/\/doi.org\/10.2119\/molmed.2013.00005","journal-title":"Mol Med"},{"issue":"12","key":"7_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4161\/epi.22901","volume":"7","author":"M Kanduri","year":"2012","unstructured":"Kanduri M, Marincevic M, Halldorsdottir AM et al (2012) Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles. Epigenetics 7(12):1435\u20131442. https:\/\/doi.org\/10.4161\/epi.22901","journal-title":"Epigenetics"},{"issue":"11","key":"7_CR36","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3324\/haematol.2011.044792","volume":"96","author":"E Arvaniti","year":"2011","unstructured":"Arvaniti E, Ntoufa S, Papakonstantinou N et al (2011) Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica 96(11):1644\u20131652. https:\/\/doi.org\/10.3324\/haematol.2011.044792","journal-title":"Haematologica"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2119\/molmed.2011.00480","volume":"18","author":"S Ntoufa","year":"2012","unstructured":"Ntoufa S, Vardi A, Papakonstantinou N et al (2012) Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol Med 18:1281\u20131291. https:\/\/doi.org\/10.2119\/molmed.2011.00480","journal-title":"Mol Med"},{"issue":"10","key":"7_CR38","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.4049\/jimmunol.1502297","volume":"196","author":"S Ntoufa","year":"2016","unstructured":"Ntoufa S, Papakonstantinou N, Apollonio B et al (2016) B cell anergy modulated by TLR1\/2 and the miR-17 approximately 92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset #4. J Immunol 196(10):4410\u20134417. https:\/\/doi.org\/10.4049\/jimmunol.1502297","journal-title":"J Immunol"},{"key":"7_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15746","volume":"8","author":"C Minici","year":"2017","unstructured":"Minici C, Gounari M, Ubelhart R et al (2017) Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia. Nat Commun 8:15746. https:\/\/doi.org\/10.1038\/ncomms15746","journal-title":"Nat Commun"},{"issue":"5","key":"7_CR40","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2014-09-600874","volume":"125","author":"P Baliakas","year":"2015","unstructured":"Baliakas P, Agathangelidis A, Hadzidimitriou A et al (2015) Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations. Blood 125(5):856\u2013859. https:\/\/doi.org\/10.1182\/blood-2014-09-600874","journal-title":"Blood"},{"issue":"2","key":"7_CR41","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","volume":"1","author":"P Baliakas","year":"2014","unstructured":"Baliakas P, Hadzidimitriou A, Sutton LA et al (2014) Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. Lancet Haematol 1(2):e74\u2013e84. https:\/\/doi.org\/10.1016\/S2352-3026(14)00005-2","journal-title":"Lancet Haematol"},{"issue":"1","key":"7_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ajh.23591","volume":"89","author":"I Giudice Del","year":"2014","unstructured":"Del Giudice I, Chiaretti S, Santangelo S et al (2014) Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients\u2019 prognosis. Am J Hematol 89(1):74\u201382. https:\/\/doi.org\/10.1002\/ajh.23591","journal-title":"Am J Hematol"},{"issue":"8","key":"7_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024313","volume":"6","author":"F Maura","year":"2011","unstructured":"Maura F, Cutrona G, Fabris S et al (2011) Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia. PLoS One 6(8):e24313. https:\/\/doi.org\/10.1371\/journal.pone.0024313","journal-title":"PLoS One"},{"issue":"13","key":"7_CR44","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","volume":"15","author":"D Rossi","year":"2009","unstructured":"Rossi D, Spina V, Cerri M et al (2009) Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 15(13):4415\u20134422. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-3266","journal-title":"Clin Cancer Res"},{"issue":"17","key":"7_CR45","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1158\/1078-0432.CCR-16-3100","volume":"23","author":"A Xochelli","year":"2017","unstructured":"Xochelli A, Baliakas P, Kavakiotis I et al (2017) Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: shared and distinct immunogenetic features and clinical outcomes. Clin Cancer Res 23(17):5292\u20135301. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3100","journal-title":"Clin Cancer Res"},{"issue":"4","key":"7_CR46","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.3324\/haematol.2017.182634","volume":"103","author":"P Baliakas","year":"2018","unstructured":"Baliakas P, Mattsson M, Hadzidimitriou A et al (2018) No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica 103(4):e158\u2013e161. https:\/\/doi.org\/10.3324\/haematol.2017.182634","journal-title":"Haematologica"},{"issue":"2","key":"7_CR47","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/leu.2016.322","volume":"31","author":"K Stamatopoulos","year":"2017","unstructured":"Stamatopoulos K, Agathangelidis A, Rosenquist R et al (2017) Antigen receptor stereotypy in chronic lymphocytic leukemia. Leukemia 31(2):282\u2013291. https:\/\/doi.org\/10.1038\/leu.2016.322","journal-title":"Leukemia"},{"key":"7_CR48","unstructured":"Agathangelidis A, Bystry V, Hadzidimitriou A et al (2015) Higher-order immunoglobulin sequence relations for major subsets of chronic lymphocytic leukemia: uniqueness versus equivalence. In: Paper presented at the 20th congress of the European Hematology Association (EHA), Vienna"},{"issue":"10","key":"7_CR49","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1182\/blood-2002-11-3456","volume":"101","author":"FI Camacho","year":"2003","unstructured":"Camacho FI, Algara P, Rodriguez A et al (2003) Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood 101(10):4042\u20134046. https:\/\/doi.org\/10.1182\/blood-2002-11-3456","journal-title":"Blood"},{"issue":"8","key":"7_CR50","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1182\/blood-2003-05-1383","volume":"102","author":"D Kienle","year":"2003","unstructured":"Kienle D, Krober A, Katzenberger T et al (2003) VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 102(8):3003\u20133009. https:\/\/doi.org\/10.1182\/blood-2003-05-1383","journal-title":"Blood"},{"issue":"12","key":"7_CR51","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","volume":"101","author":"J Orchard","year":"2003","unstructured":"Orchard J, Garand R, Davis Z et al (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101(12):4975\u20134981. https:\/\/doi.org\/10.1182\/blood-2002-06-1864","journal-title":"Blood"},{"issue":"3","key":"7_CR52","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/modpathol.2008.199","volume":"22","author":"M Schraders","year":"2009","unstructured":"Schraders M, Oeschger S, Kluin PM et al (2009) Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity. Mod Pathol 22(3):416\u2013425. https:\/\/doi.org\/10.1038\/modpathol.2008.199","journal-title":"Mod Pathol"},{"issue":"4","key":"7_CR53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1600-0609.2002.01662.x","volume":"68","author":"M Thorselius","year":"2002","unstructured":"Thorselius M, Walsh S, Eriksson I et al (2002) Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol 68(4):217\u2013224","journal-title":"Eur J Haematol"},{"issue":"10","key":"7_CR54","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1182\/blood-2002-11-3479","volume":"101","author":"SH Walsh","year":"2003","unstructured":"Walsh SH, Thorselius M, Johnson A et al (2003) Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 101(10):4047\u20134054. https:\/\/doi.org\/10.1182\/blood-2002-11-3479","journal-title":"Blood"},{"issue":"11","key":"7_CR55","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","volume":"118","author":"A Hadzidimitriou","year":"2011","unstructured":"Hadzidimitriou A, Agathangelidis A, Darzentas N et al (2011) Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood 118(11):3088\u20133095. https:\/\/doi.org\/10.1182\/blood-2011-03-343434","journal-title":"Blood"},{"issue":"5","key":"7_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.semcancer.2011.09.009","volume":"21","author":"A Agathangelidis","year":"2011","unstructured":"Agathangelidis A, Hadzidimitriou A, Rosenquist R et al (2011) Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells. Semin Cancer Biol 21(5):299\u2013307. https:\/\/doi.org\/10.1016\/j.semcancer.2011.09.009","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"7_CR57","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ajpath.2015.02.006","volume":"185","author":"A Xochelli","year":"2015","unstructured":"Xochelli A, Sutton LA, Agathangelidis A et al (2015) Molecular evidence for antigen drive in the natural history of mantle cell lymphoma. Am J Pathol 185(6):1740\u20131748. https:\/\/doi.org\/10.1016\/j.ajpath.2015.02.006","journal-title":"Am J Pathol"},{"issue":"7","key":"7_CR58","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.ajpath.2017.02.017","volume":"187","author":"E Pouliou","year":"2017","unstructured":"Pouliou E, Xochelli A, Kanellis G et al (2017) Numerous ontogenetic roads to mantle cell lymphoma: immunogenetic and immunohistochemical evidence. Am J Pathol 187(7):1454\u20131458. https:\/\/doi.org\/10.1016\/j.ajpath.2017.02.017","journal-title":"Am J Pathol"},{"issue":"6","key":"7_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang ML, Rule S, Martin P et al (2013) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med 369(6):507\u2013516. https:\/\/doi.org\/10.1056\/NEJMoa1306220","journal-title":"N Engl J Med"},{"issue":"7","key":"7_CR60","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/leu.2012.3","volume":"26","author":"V Bikos","year":"2012","unstructured":"Bikos V, Darzentas N, Hadzidimitriou A et al (2012) Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia 26(7):1638\u20131646. https:\/\/doi.org\/10.1038\/leu.2012.3","journal-title":"Leukemia"},{"issue":"10","key":"7_CR61","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","volume":"95","author":"S Zibellini","year":"2010","unstructured":"Zibellini S, Capello D, Forconi F et al (2010) Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 95(10):1792\u20131796. https:\/\/doi.org\/10.3324\/haematol.2010.025437","journal-title":"Haematologica"},{"issue":"5","key":"7_CR62","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/leu.2011.311","volume":"26","author":"E Kostareli","year":"2012","unstructured":"Kostareli E, Gounari M, Janus A et al (2012) Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59\/IGKV3-20 receptors with rheumatoid factor activity. Leukemia 26(5):1127\u20131131. https:\/\/doi.org\/10.1038\/leu.2011.311","journal-title":"Leukemia"},{"key":"7_CR63","doi-asserted-by":"crossref","unstructured":"Xochelli A, Bikos V, Polychronidou E et al (2015) Unique versus common: disease-biased immunoglobulin gene repertoires along with public antigen receptor stereotypes in marginal zone B-cell lymphoproliferations. In: 57th ASH annual meeting, Orlando, FL","DOI":"10.1182\/blood.V126.23.1479.1479"},{"issue":"1","key":"7_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","volume":"13","author":"JL Xu","year":"2000","unstructured":"Xu JL, Davis MM (2000) Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13(1):37\u201345","journal-title":"Immunity"},{"issue":"4","key":"7_CR65","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jmr.679","volume":"17","author":"Y Barrios","year":"2004","unstructured":"Barrios Y, Jirholt P, Ohlin M (2004) Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit 17(4):332\u2013338. https:\/\/doi.org\/10.1002\/jmr.679","journal-title":"J Mol Recognit"},{"issue":"Web Server","key":"7_CR66","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet X, Lefranc MP, Giudicelli V (2008) IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36(Web Server):W503\u2013W508. https:\/\/doi.org\/10.1093\/nar\/gkn316","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"7_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/prot.340170108","volume":"17","author":"S Henikoff","year":"1993","unstructured":"Henikoff S, Henikoff JG (1993) Performance evaluation of amino acid substitution matrices. Proteins 17(1):49\u201361. https:\/\/doi.org\/10.1002\/prot.340170108","journal-title":"Proteins"},{"issue":"1","key":"7_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bioinformatics\/14.1.55","volume":"14","author":"I Rigoutsos","year":"1998","unstructured":"Rigoutsos I, Floratos A (1998) Combinatorial pattern discovery in biological sequences: the TEIRESIAS algorithm. Bioinformatics 14(1):55\u201367","journal-title":"Bioinformatics"},{"issue":"2","key":"7_CR69","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/j.1460-2075.1992.tb05092.x","volume":"11","author":"PM Kirkham","year":"1992","unstructured":"Kirkham PM, Mortari F, Newton JA et al (1992) Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J 11(2):603\u2013609","journal-title":"EMBO J"},{"issue":"23","key":"7_CR70","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btv456","volume":"31","author":"V Bystry","year":"2015","unstructured":"Bystry V, Agathangelidis A, Bikos V et al (2015) ARResT\/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy. Bioinformatics 31(23):3844\u20133846. https:\/\/doi.org\/10.1093\/bioinformatics\/btv456","journal-title":"Bioinformatics"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12859-018-2381-1","volume":"19","author":"E Polychronidou","year":"2018","unstructured":"Polychronidou E, Kalamaras I, Agathangelidis A et al (2018) Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia. BMC Bioinformatics 19:414","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"7_CR72","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.4049\/jimmunol.1602050","volume":"198","author":"AW Langerak","year":"2017","unstructured":"Langerak AW, Bruggemann M, Davi F et al (2017) High-throughput immunogenetics for clinical and research applications in immunohematology: potential and challenges. J Immunol 198(10):3765\u20133774. https:\/\/doi.org\/10.4049\/jimmunol.1602050","journal-title":"J Immunol"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9151-8_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:06:25Z","timestamp":1694631985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9151-8_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493991501","9781493991518"],"references-count":72,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9151-8_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"19 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}